Joshua Muia on Genetic Alterations Affecting ADAMTS13 Maturation at IPS 2025
Joshua Muia, Associate Investigator at Versiti Blood Research Institute, shared on LinkedIn:
”It was an exciting week presenting work from laboratory at the International Proteolysis Society’s 13th Biannual Meeting in Buzios, Rio de Janeiro, Brazil.”
The International Proteolysis Society’s 13th Biannual Meeting , held in Búzios, Brazil, from October 26–30, 2025, offered an excellent opportunity for scholars and researchers to gather and engage in meaningful discussions on a wide range of topics.
The meeting also served as a valuable platform for networking and building important professional connections within the research community.
At the meeting Joshua Muia presented research from the Versiti Blood Research Institute laboratory on genetic alterations affecting ADAMTS13 maturation.
Stay updated with Hemostasis Today.
-
Jul 9, 2026, 09:35Pradeebha Muthukumar: Do You Know the Signs of Anemia?
-
Jul 9, 2026, 09:24Maryam Majid: Machine Learning for Anemia Risk Prediction
-
Jul 9, 2026, 08:46Jordan Agay: Folate Deficiency in Patients Receiving PARP Inhibitors
-
Jul 9, 2026, 08:29Laura Katz: Is Human Lactoferrin Better Than Bovine Lactoferrin?
-
Jul 9, 2026, 08:17Anziya Sabeer: AI-Driven Non-Invasive Anemia Detection
-
Jul 9, 2026, 07:37Variable Mechanisms of ADAMTS13 Inhibition by Autoantibodies in iTTP – JTH
-
Jul 9, 2026, 07:31DHR-Sponsored Training Programme at ICMR-CRMCH Week 2 – Day 4 – ICMR-NIRBID
-
Jul 9, 2026, 06:03Barbara Adams Krolak: ISTH Launches Global Women’s Health Hub
-
Jul 9, 2026, 05:49Abdul Mannan: A Low Platelet Count is not Always a Bone Marrow Problem